Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2005-001132-72-IT
EUCTR2005-001132-72-IT
Active, not recruiting
Not Applicable

A Phase 2 Study of combined modality treatment with primary chemotherapy followed by endoscopic laser resection in intermediate stage laryngeal squamous cell carcinoma.

ISTITUTO EUROPEO DI ONCOLOGIA0 sites42 target enrollmentJanuary 3, 2006
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsSQUAMOUS CELL CARCINOMA OF THE LARYNGXMedDRA version: 6.1Level: PTClassification code 10018395
DrugsCISPLATINO TEVA IV 1FL50MGFLUOROURACILE TEVA 1 FL 5 GNAVELBINE 10MG/ML FL1ML

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
SQUAMOUS CELL CARCINOMA OF THE LARYNGX
Sponsor
ISTITUTO EUROPEO DI ONCOLOGIA
Enrollment
42
Status
Active, not recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 3, 2006
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Phase I and II trial of combination therapy using nab-Paclitaxel+Pertuzumab+Trastuzumab for HER2 positive metastatic breast cancermetastatic breast cancer
JPRN-UMIN000035869The University of Tokushima Graduate School, Depertment of Thoracic, Endocrine surgery and Oncology, Institute of Health Bioscience30
Completed
Phase 2
Phase II study comparing combination therapy with carboplatin plus pemetrexed vs combination therapy with pemetrexed plus bevacizumab in chemo-naive elderly patients with advanced non-squamous non-small-cell lung cancer (HSR1402).advanced non-squamous non-small-cell lung cancer
JPRN-UMIN000014302Hamamatsu Univ. School of Medicine64
Recruiting
Phase 2
A randomised phase II trial of combined therapy with CPT-11/CDDP versus CPT-11 alone in second-line treatment of advaneced or recurrent gastric cancer resistant to Docetaxel/Cisplatin/TS-1 (DCS) therapyGastric Cancer
JPRN-UMIN000003141Sapporo Medical University School of Medicine Dept. of Internal Medicine(4)80
Active, not recruiting
Phase 2
A phase II study for HER2 amplified advanced solid tumors (JUPITER trial)Solid tumorsHER2, solid tumorD009369
JPRN-jRCT2031180150Ikeda Sadakatsu38
Completed
Phase 1
Phase I/II study on combination therapy consisting of a fixed dose-rate infusion of gemcitabine with oral fluorinated pyrimidine compound S-1 (FGS) in patients with gemcitabine-refractory advanced pancreatic cancerPatients with gemcitabine-refractory metastatic pancreatic cancer
JPRN-C000000450ational Cancer Center Hospital, Hepatobiliary and Pancreatic Oncology Division40